Our central project, Long COVID Justice, has created a new resource list for resisting mask bans. The list includes links to organizing toolkits, information about resistance efforts across the U.S., news coverage, and more.
Tell the CDC: New CDC COVID-19 isolation guidance weakens labor protections, discriminates against high-risk people, and does not match the science
Strategies for High Impact and our Long COVID Justice project have signed on to Pan End It’s new letter to CDC Director Mandy Cohen, which demands that the CDC take a strong stand for public health and resist political and corporate pressure to downplay the dangers of the ongoing COVID-19 pandemic.
The CDC’s recently revised COVID isolation guidance weakens labor protections, discriminates against high-risk people, and does not match the science. In response, this letter calls for the CDC to make changes including revising their shortened COVID isolation guidelines, working with other agencies in support of universal paid sick leave, emphasizing masking and testing as core prevention strategies, and publishing more specific information on high-risk conditions.
Use this template to add your name and send your own personalized letter to the CDC.
New interview with Strategies for High Impact's inaugural BIPOC Fellow Abdul-Aliy Muhammad and Advisory Team member Pato Hebert →
A visionary conversation on living, writing, organizing, and making art around HIV and Long COVID with S4HI BIPOC Fellow Abdul-Aliy Muhammad and Advisory Council member Pato Hebert. Thanks to our partners at Narrative Initiative for editing and publishing the interview.
Read morePeople with Long COVID Urge NIH: Fund Vital, Comprehensive Long COVID Treatment Research, Not Debunked, Dangerous Approaches →
Three years into the ongoing COVID pandemic, an impassioned, growing group of patients and advocates for Long COVID and associated diseases (LCAD) is urging NIH to prioritize full funding of strategic research on therapeutics and to immediately halt plans to fund two problematic studies in the initial set of trials under the RECOVER Initiative.
Read more